MyronSCohenMD

PubMed

• Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084.
  Mark A Marzinke, Kelong Han, Brett Hanscom, Xu Guo, Estelle Piwowar-Manning
  Antimicrobial Agents and Chemotherapy. 2024-11-06
• HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.
  Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, Paul Richardson, Joseph Szewczyk
  AIDS Research and Human Retroviruses. 2024-10-28
• Updated Risk Score Algorithms for Acute HIV Infection Detection at a Sexually Transmitted Infections Clinic in Lilongwe, Malawi.
  Griffin J Bell, Jane S Chen, Courtney N Maierhofer, Mitch Matoga, Sarah E Rutstein
  Journal of Acquired Immune Deficiency Syndromes. 2024-09-09

Journal Articles

• Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact  
  Connie Celum, Myron S Cohen, Wafaa El-Sadr, The New England Journal of Medicine
• Monoclonal Antibodies for Prevention and Treatment of COVID-19  
  John R Mascola, Myron S Cohen, JAMA
• Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence  
  Myron Cohen, MD, The New England Journal of Medicine
• HIV-1 Transmission Among Persons with Acute HIV-1 Infection in Malawi: Demographic, Behavioral and Phylogenetic Relationships  
  Mina C Hosseinipour, Sarah E Rutstein, Myron S Cohen, Clinical Infectious Diseases
• Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in Low-Risk HIV-Uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled Trial  
  Susan H Eshleman, Joseph J Eron, Raphael J Landovitz, Myron S Cohen, Jeremy Sugarman, Mark A Marzinke, Craig W Hendrix, PLoS One
• Using Primer-ID Deep Sequencing to Detect Recent HIV-1 Infection  
  Ann M Dennis, Joseph J Eron, Myron S Cohen, Christopher J Sellers, The Journal of Infectious Diseases
• Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Conception Efficacy Trials  
  Gilbert PB, Juraska M, Decamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J..., Statistical Communications in Infectious Diseases, 1/6/2017
• Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection  
  Mangal TD; UNAIDS Working Group on CD4 Progression and Mortality Amongst HIV Seroconverters including the CASCADE Collaboration in EuroCoord, AIDS, 1/1/2017
• Toward an Endgame: Finding and Engaging People Unaware of Their HIV-1 Infection in Treatment and Prevention  
  Burns DN, Degruttola V, Pilcher CD, Kretzschmar M, Gordon CM, Flanagan EH, Duncombe C, Cohen MS, AIDS Res Hum Retroviruses, 1/11/2014
• Decreasing Excess Mortality of HIV-infected Patients Initiating Antiretroviral Therapy: Comparison with Mortality in General Population in China, 2003 - 2009  
  Zhu H, Napravnik S, Eron JJ, Cole SR, Ma Y, Wohl DA, Dou Z, Zhang Y, Liu Z, Zhao D, Yu L, Liu X, Cohen MS, Zhang F, J Acquir Immune Defic Syndr, 1/8/2013
• Relative resistance of HIV-1 founder viruses to control by interferon-alpha  
  Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman MM, Pellegrino P, Williams I, Cohen MS, Gao F, Shaw GM, Hahn BH, Ochsenbauer C, Kappes JC, Borr..., Retrovirology, 1/1/2013
• Vertical T cell immunodominance and epitope entropy determine HIV-1 escape  
  Liu MK, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M, Treurnicht F, Hraber P, Riou C, Gray C, Ferrari G, Tanne..., J Clin Invest, 1/1/2013
• Linkage From HIV Testing to Care: A Positive Test Often Leads Nowhere  
  El-Sadr WM, Gamble TR, Cohen MS, Sex Transm Dis, 1/1/2013
• HIV prevention: great achievements, more challenges ahead  
  El-Sadr WM, Serwadda DM, Sista N, Cohen MS, J Acquir Immune Defic Syndr, 1/1/2013
• The detection and management of early HIV infection: a clinical and public health emergency  
  Smith MK, Rutstein SE, Powers KA, Fidler S, Miller WC, Eron JJ Jr, Cohen MS, J Acquir Immune Defic Syndr, 1/1/2013
• Antiretroviral pharmacology in mucosal tissues  
  Thompson CG, Cohen MS, Kashuba AD, J Acquir Immune Defic Syndr, 1/1/2013
• Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 ...  
  Ping LH, Joseph SB, Anderson JA, Abrahams MR, Salazar-Gonzalez JF, Kincer LP, Treurnicht FK, Arney L, Ojeda S, Zhang M, Keys J, Potter EL, Chu H, Moore P, Salazar MG, ..., J Virol, 1/1/2013
• Antiretroviral therapy for prevention is a combination strategy  
  McNairy ML, Cohen MS, El-Sadr WM, Curr HIV/AIDS Rep, 1/1/2013
• Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052)  
  Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N,..., J Infect Dis, 1/1/2013
• Water, sanitation, and hygiene interventions to improve health among people living with HIV/AIDS: a systematic review  
  Peletz R, Mahin T, Elliott M, Harris MS, Chan KS, Cohen MS, Bartram JK, Clasen TF, AIDS, 1/1/2013
• Cost-effectiveness of HIV treatment as prevention in serodiscordant couples  
  Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCa..., N Engl J Med, 1/1/2013
• Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosing  
  Greener BN, Patterson KB, Prince HM, Sykes CS, Adams JL, Dumond JB, Shaheen NJ, Madanick RD, Dellon ES, Cohen MS, Kashuba AD, J Acquir Immune Defic Syndr, 1/1/2013
• Using antiretroviral therapy to control heterosexual transmission of HIV: what is the role of early transmission  
  Cohen MS, Dye, C, Fraser, C, Miller, WC, Powers KA, Williams,B G., PLOS Med, 1/10/2012
• ART and population level prevention of HIV: Ecology, observation and interpretation  
  Smith, K, Muessig, KE, Powers, KS Miller, WC and Cohen MS, PLOS Med, 1/10/2012
• Antiviral agents and HIV prevention: controversies, conflicts, and consensus  
  Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba AD, AIDS, 1/1/2012
• Join now to see all

Books/Book Chapters

• Mandell, Douglas, and Bennett�s Prinicples and Practice of Infectious Diseases 
  Chapter: The Acutely Ill Patient with Fever and Rash. 
  Weber D, Juliano J, Cohen MSEditors: Drs. Bennett, Dolin, and Blaser.2018
• Disease Control Priorities: Major Infectious Diseases (vol 6) 
  Chapter: Effectiveness and Cost-Effectiveness of Treatment as Prevention for HIV. 
  Holmes CB, Hallett TB, Walensky RP, Barnighausen T, Pillay Y, Cohen MSEditors: Holmes, K.K., S. Bertozzi, B.R. Bloom, and P. Jha.World Bank2017
• Cecil Textbook of Internal Medicine 
  Chapter: Prevention of HIV Infection. 
  Del Rios C and Cohen MS2014
• Cecil Textbook of Internal Medicine 
  Chapter: Approach to the Patient with STDs. 
  Cohen MS2011
• The AIDS Pandemic: Impact on Science and Society 
  Chapter: HIV treatment meets prevention: antiretroviral therapy as prophylaxis. AIDS in the 21st Century. 
  Cohen MS and Hosseinipour, MEditors: Mayer and Pizer.Elsevier2004
• Sexually Transmitted Diseases 
  Chapter: Genitourinary mucosal defenses. 
  Cohen MS and Anderson DEditors: Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, Cates W. Jr., Lemon SM, and Stamm WE.McGraw-Hill Book Company, New York, NY2000
• The Medical Management of AIDS. 
  Chapter: Global Prevention of HIV Transmission. 
  Page 499 - 512Cohen MS, Dallabetta G, Holmes KK, and Cates WEditors: W.B. Saunders Company.1999
• Sexually Transmitted Diseases: Methods and Protocols 
  Chapter: Collection and processing of seminal plasma for the quantitation of HIV-1 RNA by NASBA and RT-PCR. 
  Fiscus SA and Cohen MSEditors: Peeling RW and Sparling PF.Humana Press1998
• Clinical Immunology: Principles and Practice (vol 1) 
  Chapter: Immune responses to extracellular bacteria. 
  Page 479 - 502Musher D, Cohen MS, and Baker, CEditors: Rich, R, Fleisher, TA, Schwartz, BD, Sheaarer, WT, Strober, W.Mosby-Year Book, Inc1996
• Principles and Practice of Infectious Diseases. 
  Chapter: The acutely ill patient with fever and rash. 
  Weber DJ, Gammon WR, and Cohen MSEditors: GL Mandell, JE Bennett, R Dolin.Churchill Livingstone Inc, New York, NY1995
• Infectious Diseases in an Age of Change: The Impact of Human Ecology and Behavior on Disease Transmission 
  Chapter: Vaccines for bacterial sexually transmitted infections: A realistic goal? 
  Page 213 - 233Sparling PF, Elkins C, Wyrick PB, and Cohen MSEditors: Roizman B.National Academy Press, Washington, DC1995
• Infectious Disease Clinics of North America 
  Chapter: Vaccines for Classic Sexually Transmitted Diseases 
  Page 859 - 876Adimora A, Sparling PF, and Cohen MSEditors: Cohen, M.S., Hook E., Hitchcock, PJ.W.B. Saunders Company, Philadelphia, PA1994
• Oxygen Radicals. 
  Chapter: Free radical formation from organic hydroperoxides in isolated human polymorphonuclear neutrophils. 
  Chamulitrat W, Mason RP, and Cohen MSEditors: K Yagi, M Kondo, E Niki and T. Yoshikawa.Elsevier Science Publishers B.V.1992
• Pharmacologic Therapeutics 
  Chapter: Penicillins, Cephalosporins and Monobactarams. 
  Hamilton H and Cohen MSEditors: Paul L. Munson.Springer Verlag, Berlin1992
• Infectious Disease in Emergency Medicine 
  Chapter: Infection in the immunocompromised host. 
  Serody J and Cohen MSEditors: J.C. Brillman and R.W. Quenzer.Little Brown, New York, NY1992
• Current Topics in Critical Care. 
  Chapter: Cost containment of antibiotics in the intensive care unit. 
  Hamilton H, Byron CS, and Cohen MSEditors: David H. Gremillion.Lippincott & Co, Philadelphia, PA1992
• Advances in Host Defense Mechanisms. Vol. IV. 
  Chapter: Mucosal defenses and microbial pathogens of the genital tract. 
  Page 39 - 55Cohen MS and Heine RPEditors: T.C. Quinn, J.I. Gallin, and A.S. Fauci.Raven Press, New York, NY1992
• AIDS and Human Reproduction. 
  Chapter: Mucosal defenses and HIV. 
  Page 61 - 69Cohen MSEditors: F. Melica.Springer-Verlag, New York, NY1992
• Vaginitis and Vaginosis 
  Chapter: Vaginal Mucosal Defenses. 
  Page 33 - 37Cohen MSEditors: B. Horowitz and P.-A. Mardh.Wiley-Liss, Inc., New York, NY1991
• Chemistry, Biology & Medical Aspects 
  Chapter: Phagocytes: free radicals, lactoferrin and the lactoferrin receptor. 
  Page 658 - 662Cohen MS, Serody J, Britigan BE, Rosen G, and Charniga L.M.Editors: K.J.A. Davies.Pergamon Press, New York, NY1991
• Principles and Practice of Infectious Diseases 
  Chapter: The acutely ill patient with fever and rash. 
  Page 479 - 488Weber DJ, Gammon R, and Cohen MSEditors: Mandell, G.L., Douglas, R.G., and Bennett.Churchill Livingstone, New York, NYEdition 3rd,1990
• The Respiratory Burst 
  Chapter: The expanded phagocytic respiratory burst: Bacterial competition for oxygen and its stimulation by host factors. 
  Page 99 - 116Cohen MS and Britigan BEEditors: Sbarra, A.S., and Strauss, S..Plenum Press1988
• Osteoporosis 1984 
  Chapter: Mechanisms of estradiol's actions on bone. 
  Page 513 - 551Gray TK, Korach K, Nabell LM, Flynn TC, Gray KM, Dodd RC, Sivam G, Williams M, and Cohen MSEditors: Christiansen, J.S. Johansen and B.J. Riis.Norhaven A/S, Viborg, Denmark1987
• The Pathogenic Neisseria. 
  Chapter: Metabolic, structural, and pathogenic changes of Neisseria gonorrhoea exposed to human serum: An alternative view of the interaction between bacteria and the host. 
  Page 445 - 452Britigan BE, Chai Y, and Cohen MSEditors: G.K. Schoolnick.ASM, Washington, DC1985
• Sexually Transmitted Diseases 
  Chapter: Mucosal defenses. 
  Page 173 - 198Cohen MS, Colleen S, and Mardh PEditors: Holmes, K.K., Mardh, P.A., and Sparling, P.F..McGraw-Hill Book Company, New York, NY1984
• Join now to see all

Lectures

• HIV Vaccines (X2) 
  Keystone Symposia, Keystone, Colorado - 2/10/2013
• B Cell Development and Function (X1) 
  Keystone Symposia, Keystone, Colorado - 2/10/2013
• HIV Management 2012: The New York Course 
  The New York Course : HIV Management, New York, New York - 5/10/2012

Other

• PEPFAR, Launched as an Emergency Response to AIDS, Has Built a Bridge to the Future 
  Myron Cohen, MD, STAT
  https://www.doximity.com/articles/04aeec55-0bc9-42e4-b378-30c377f7ecc1
  UpToDate, Wolters Kluwer Health - 2012-11-26
• Syndromic treatment of gonococcal and chlamydial infection in women seeking primary care for genital discharge syndrome: decision-making. 
  Behets F, Miller WC, Cohen MS, Bulletin of the World Health Organization
  1/1/2001
• Approaches to control sexually transmitted diseases Haiti from 1992 through 1995. 
  Behets F, Genece E, Narcisse M, Dallabetta G, Cohen MS, WHO Bulletin
  1/1/1998
• After the Revolution: Medicine in China. 
  Cohen MS, American College of Physicians Observer I
  1/1/1981
• Join now to see all